RKDA · Arcadia Biosciences, Inc.
$0.48
-0.14 (-23.12%)
At close · Aug 17
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of these condensed consolidated financial statements, which raises substantial doubt about the Company's ability to continue as a going concern, and the audit opinion on our 2025 audited consolidated financial statements includes a going concern explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.50M
Shares
2.41M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.48
Open$0.62
Day$0.42–0.64
52W close$0.48–5.48
Avg vol 30d169K
Short int3K · 0.1% float · 1.0d
Short vol17%
Last earningsNov 7, 2025
DataMar 2023–Aug 2026
Filing10-Q · Aug 13
Raw chart and full-history price indicators begin at the captured split on Mar 1, 2023; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−73%
below
Price vs 50-day avg
−33%
below
RSI (14)
33
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−28%
trailing
6-month return
−74%
trailing
YTD return
−76%
this year
Relative strength
−87%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+6% holders QoQ · +8 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.15% of float · ▼ -63.8% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
17 holders — near 3-yr high, broad support
Squeeze score
17
low risk · 0–100
Fundamentals
Revenue growth
−4%
Y/Y
EPS growth
+67%
Y/Y
Free cash flow
$-4.7M
Balance sheet
$259.0K
net cash
Quant / Vol
risk profile
Volatility
106%
annualized · 1-yr
Max drawdown
−91%
past year
ATR
18.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Prior guidance
period ended
· from the Earnings Call filed Jun 30, 2024
Total revenues
· full-year 2024
$5.3M
Gross margins
· full-year 2024
40% – 42%
Gross profit
· full-year 2024
at least $2M
Use of cash
· full-year 2024
$7M – $7.5M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−73%
Bearish
Price vs 50-day avg
−33%
Bearish
RSI (14)
33
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+6% holders QoQ · +8 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.15% of float · ▼ -63.8% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
17 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $5
vs 200-day avg -73%
vs 50-day avg -33%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RKDA
this stock
Arcadia Biosciences, Inc.
|
$1.50M | -75.7% | -3.7% | — | 0.1% |
|
KHC
Kraft Heinz Co
|
$29.35B | +2.1% | -0.1% | — | 7.3% |
|
GIS
General Mills Inc
|
$20.27B | -18.3% | +4.1% | — | 9.2% |
|
MKC
Mccormick & Co Inc
|
$14.70B | -20.8% | +1.7% | 9.1 | 5.1% |
|
JBS
Jbs N.V.
|
$14.39B | -6.8% | — | — | 3.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Mar 1, 2023; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RKDA | -26.4% | -27.6% | -74.3% | -23.2% | -75.8% |
| SPY | -0.1% | +4.1% | +12.4% | +3.4% | +13.3% |
| vs SPY | -26.3% | -31.7% | -86.7% | -26.6% | -89.1% |